C. Serradeil‐Le Gal

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

C. Serradeil‐Le Gal, Jean Wagnon, Corinne Garcia et al. · Journal of Clinical Investigation · 1993 · 273 citations · Full text

Medicine, Pharmacology, Physiology +11

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

C. Serradeil‐Le Gal, C Lacour, G Valette et al. · Journal of Clinical Investigation · 1996 · 249 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Endothelin action in rat liver. Receptors, free Ca2+ oscillations, and activation of glycogenolysis.

C. Serradeil‐Le Gal, Catherine Jouneaux, A Sanchez-Bueno et al. · Journal of Clinical Investigation · 1991 · 110 citations · Full text

Life Sciences, Pharmacology, Cell Signaling +13

Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors.

Ariane Mallat, Anne-Marie Préaux, C. Serradeil‐Le Gal et al. · Journal of Clinical Investigation · 1996 · 104 citations · Full text

Life Sciences, Cell Biology, Pharmacology +14

Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells

C. Serradeil‐Le Gal, Jean‐Marc Herbert, Chantal Delisée et al. · American Journal of Physiology-Heart and Circulatory Physiology · 1995 · 53 citations

Medicine, Pharmacology, Cell Signaling +15